Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19)
Not Applicable
Recruiting
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003050
- Lead Sponsor
- Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Comply with the diagnostic criteria for COVID-19 in the Diagnosis and Treatment Program for pneumonia caused by novel coronavirus infection (Trial Version 5), meet the the criteria of severe and critical type;
(2) Agree to participate in the study and the patient or legal guardian signs the informed consent form.
Exclusion Criteria
(1) It is difficult to administer to patients by oral or nasal feeding;
(2) Pregnant women, as well as patients with other malignancies such as malignant tumors, mental illnesses, and patients who are not considered suitable for study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cure / mortality rate;Becomes negative time of COVID-19;TCM symptom score;
- Secondary Outcome Measures
Name Time Method Indicators of inflammation (CRP, ESR);Blood gas analysis;Chest CT;Major symptom relief time;